Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Ligand Pharmaceuticals Inc
NASDAQ:LGND
Price:
304.8
USD
0.68%
Market Cap:
$6.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
US |
|
E
|
Endesa SA
XMUN:ENA
|
ES |
|
U
|
U Power Ltd
NASDAQ:UCAR
|
CN |
|
Interfoundry Inc
OTC:ITFY
|
US |
|
TechnoPro Holdings Inc
F:30T
|
JP |
|
3
|
3M Co
BMV:MMM
|
US |
|
D
|
Dexus
OTC:DEXSF
|
AU |
|
American Tower Corp
NYSE:AMT
|
US |
Wall St Price Targets
LGND Price Forecast
Based on 14 analysts
Based on 14 analysts
+15% Upside
from
$304.8
today
Ligand Pharmaceuticals Inc (LGND)’s 12-month stock price forecast through October 2027 has a consensus target of $351.9, implying 15% upside. The forecast is based on price targets from 14 Wall Street analysts.
LGND Analyst Rating
Based on 7 analysts
Based on 7 analysts
Analysts rate LGND Strong buy, with 7 of 7 recommending Buy or Strong buy.
Ligand Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LGND's stock price target?
Price Target
351.9
USD
351.9
USD
According to Wall Street analysts, the average 1-year price target for LGND is 351.9 USD with a low forecast of 249.47 USD and a high forecast of 416.85 USD.
What is the Revenue forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
19%
19%
Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 8 years is 19%.
What is the Gross Profit forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
21%
21%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 7 years is 21%.
What is the Pre-Tax Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
31%
31%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 31%.
What is the Net Income forecast for Ligand Pharmaceuticals Inc?
Projected CAGR
26%
26%
The compound annual growth rate for Net Income over the next 7 years is 26%.